Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
1.870
+0.010 (0.54%)
Feb 21, 2025, 4:00 PM EST - Market closed
Alector Employees
Alector had 244 employees as of December 31, 2023. The number of employees decreased by 29 or -10.62% compared to the previous year.
Employees
244
Change (1Y)
-29
Growth (1Y)
-10.62%
Revenue / Employee
$252,082
Profits / Employee
-$649,217
Market Cap
183.13M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ALEC News
- 2 days ago - Alector to Host Fourth Quarter and Full-Year 2024 Earnings Conference Call - GlobeNewsWire
- 5 weeks ago - Alector Reports on Recent Progress and Outlines Strategic Priorities for 2025 - GlobeNewsWire
- 2 months ago - Neurology-Focused Alector Downgraded On Failed Alzheimer's Study, BofA Securities Highlights Lack Of Catalysts - Benzinga
- 3 months ago - Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce - Benzinga
- 3 months ago - Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer's Disease and Provides Business Update - GlobeNewsWire
- 3 months ago - Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital - GlobeNewsWire
- 3 months ago - Alector Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Alector to Participate in Upcoming Healthcare Conferences - GlobeNewsWire